Valuation: Inogen, Inc.

Capitalization 243M 231M 215M 191M 343M 20.62B 378M 2.66B 989M 8.46B 914M 894M 36.55B P/E ratio 2024 *
-5.95x
P/E ratio 2025 * -6.67x
Enterprise value 146M 139M 129M 115M 206M 12.4B 227M 1.6B 595M 5.09B 550M 538M 21.98B EV / Sales 2024 *
0.44x
EV / Sales 2025 * 0.42x
Free-Float
98.22%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.96%
1 week+1.96%
Current month+1.96%
1 month+7.14%
3 months-15.38%
6 months+20.29%
Current year+80.33%
More quotes
1 week
9.52
Extreme 9.52
10.28
1 month
8.71
Extreme 8.71
11.65
Current year
5.08
Extreme 5.08
13.33
1 year
4.94
Extreme 4.935
13.33
3 years
4.13
Extreme 4.13
36.30
5 years
4.13
Extreme 4.13
82.35
10 years
4.13
Extreme 4.13
287.79
More quotes
Director TitleAgeSince
Chief Executive Officer 53 2023-11-09
Director of Finance/CFO 61 2024-03-03
Sales & Marketing - 2024-09-02
Manager TitleAgeSince
Director/Board Member 64 2014-08-05
Chairman 63 2021-12-28
Director/Board Member 57 2022-03-21
More insiders
Name Weight AuM 1st Jan change Investor Rating
0.19% 26 M€ +9.91% -
More ETFs: Inogen, Inc.
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-3.72%+1.96%+94.50%-68.71%243M
-0.53%-3.01%+10.39%-13.04%201B
-0.23%-2.09%+7.50%-23.14%109B
+0.19%-0.27%-5.27%-10.09%64.02B
-0.98%-2.50%+20.38%+106.27%48B
+1.18%+3.79%+22.72%+9.86%46.08B
-1.27%+2.37%-31.88%-39.10%31.64B
+0.58%+1.00%+32.67%+34.94%30.56B
-1.71%-3.24%-8.25%-25.60%23.25B
-0.19%-1.89%-5.04%-12.36%22.02B
Average -0.71%+1.02%+13.77%-4.10% 57.64B
Weighted average by Cap. -0.35%-0.14%+7.48%-2.26%
See all sector performances

Financials

2024 *2025 *
Net sales 330M 313M 291M 259M 464M 27.92B 512M 3.6B 1.34B 11.45B 1.24B 1.21B 49.49B 344M 326M 303M 270M 483M 29.1B 534M 3.75B 1.4B 11.94B 1.29B 1.26B 51.58B
Net income -40.51M -38.46M -35.77M -31.86M -57M -3.43B -62.93M -443M -165M -1.41B -152M -149M -6.08B -37.56M -35.67M -33.18M -29.54M -52.86M -3.18B -58.36M -411M -153M -1.31B -141M -138M -5.64B
Net Debt -97.06M -92.16M -85.72M -76.33M -137M -8.22B -151M -1.06B -394M -3.37B -364M -357M -14.57B -99.15M -94.15M -87.57M -77.98M -140M -8.4B -154M -1.08B -403M -3.45B -372M -364M -14.89B
More financial data * Estimated data
Logo Inogen, Inc.
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Employees
834
More about the company
Date Price Change Volume
24-12-05 9.900 $ -3.13% 39,613
24-12-04 10.22 $ +2.82% 218,221
24-12-03 9.940 $ -1.68% 178,858
24-12-02 10.11 $ +4.12% 192,879
24-11-29 9.710 $ +0.83% 45,051

Delayed Quote Nasdaq, December 05, 2024 at 11:10 am EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart INOGEN-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
10.22USD
Average target price
10.00USD
Spread / Average Target
-2.15%
Consensus

Quarterly revenue - Rate of surprise